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The mechanism of ascorbate action on lysyl hydrox-
ylase (LH) was investigated using cultured dermal fibro-
blasts from a patient with hydroxylysine-deficient col-
lagen disease and from appropriate control patients. 
Cells from this patient had moderately impaired LH and 
both parents had intermediate values. Prolyl hydroxyl-
ase (PH) was normal in these 3 cell lines and the ratio 
between LH and PH proved an effective genetic discrim-
inant among cell lines from different individuals express-
ing varying enzyme activity. 
Ascorbate requirements for normal and mutant en-
zymes were defined and compared. Some specificity for 
ascorbate as the principal physiological reductant was 
found. Lysyl hydroxylase activity from controls was 89% 
of maximum when dithiothreitol alone was omitted 
w-hereas only 8% of activity was present when L-ascor-
bate alone was omitted. Control activity was fully recon-
stituted when isoascorbate was substituted for L-ascor-
bate, but activity was absent when dehydroascorbate 
w-as used. 
Enzyme activity in cultured cells from this patient and 
a control was enhanced proportionately by increasing 
ascorbate concentration. At concentrations of 0.5 mM 
and above, saturation was evident and mutant enzyme 
activity was 17% of control. The apparent Kin of both 
enzymes for ascorbate was identical (0.1 mM) while the 
apparent V max of mutant enzyme was reduced to 25% 
of control. Ascorbate did not alter thermostability of 
either mutant or control enzyme, and increasing ascor-
bate concentration did not overcome competitive inhi-
bition by Cu2+ of Fe2+ -dependent enzyme activity. 
These studies demonstrated that this patient with type 
VI, Ehlers-Danlos syndrome had reduced skin collagen 
hydroxylysine caused by impaired lysyl hydroxylase, 
that this mutation was transmitted as an autosomal 
recessive trait and that the mutant enzyme had a reduced 
capacity for ascorbate. Ascorbate augmented lysyl hy-
droxylase activity by dir.ect electron donation at a fer-
rous ion-containing site of this enzyme complex. 
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Collagen is the principal structural element of connective 
tissue providing the necessary tensile strength to maintain 
organizational integrity of various organ systems [1,2]. The 
functional capacity of this extracellular fibrous protein is deter-
mined largely by sequential posttranslational modifications di-
rected toward specific amino acid residues [3-5]. Hydroxylation 
of predetermined lysyl and prolyl residues in peptide linkage is 
catalyzed by 2 distinct enzymes, lysyl hydroxylase (EC 
1.14.11.4) and prolyl hydroxylase (EC 1.14.11.2) [6]. Both are 
characteristic of a recently discovered class of dioxygenases 
which couple the stoichiometric decarboxylation of a-ketoglu-
tarate to peptidyl hydroxylation [7]. We have previously char-
acterized lysyl hydroxylase in crude lysates of cultured human 
fibroblasts, its requirements for molecular oxygen, ferrous ion, 
a-ketoglutarate, ascorbate and its genetic control in man [8]. 
Increased understanding of collagen biochemistry has con-
tributed to a growing awareness of abnonnal collagen synthesis 
and structure associated with certain human disease states 
[9,10]. Hydroxylysine-deficient collagen disease (Ehlers-DanIos 
syndrome, type VI) was the first heritable human disorder of 
collagen in which a specific molecular defect was identified. 
Amino acid analysis of extracted skin collagen from 2 affected 
sisters revealed a hydroxylysine content which was 5% of con-
trols [11]. Krane, Pinnell, and Erbe et al found that lysyl 
hydroxylase activity in lysates of cultured fibroblasts from these 
patients was reduced to between 10% and 14% of controls and 
was not further augmented by supraoptimal cofactor concen-
trations in vitro [12]. Subsequently, Quinn and Krane demon-
strated that this mutant enzyme W(l.S less stable at 37° than the 
wild type and exhibited a lower affmity for ascorbate than 
control enzyme when assayed in the presence of the sulfhydryl 
reagent dithiothreitol and ascorbate [13]. , 
Four other patients have been described with hydroxylysine-
deficient skin collagen and Ehlers-DanIos syndrome [8,14-17]. 
One of these 4 was a patient with an autosomal recessive fonn 
of Ehlers-DanIos syndrome (type VI) who had impaired lysyl 
hydroxylase activity in cultured skin fibroblasts and phenotyp-
ically normal parents. Ascorbate was identified as the principal 
physiological reductant in the reaction. While the patient was 
not ascorbate 'deficient, in vivo administration of pharmacologic 
amounts of vitamin C increased urinary hydroxylysine excretion 
and improved the patient's scar formation, muscle strength, 
bleeding time, and corneal size. Hydroxylysine content of skin 
did not increase [8]. The data contained in the present study 
characterize the biochemical interaction of ascorbate with lysyl 
hydroxylase from control and this patient's cultured skin fibro-
blasts and relate this interaction to the previously observed in 
vivo effects. 
MATERIALS AND METHODS 
Fertilized eggs were purchased from Harold Hatchery, Athens, Geor-
gia. L-[4,5-"H] lysine (21 Ci/mmo!e) and L-[3,4-J H] proline (41 Ci/ 
mmole) were purchased from Amersham/Searle Corp. a-Ketoglutarate, 
L-ascorbic acid, and a,a' -dipyridyl were obtained from Sigma Chemical 
Co. Catalase was purchased from Worthington Biochemical Corp., 
Pentex bovine albumin fraction V, fatty acid poor, from Miles Labora-
tories, Inc., and dithiothreitol (DTT) from Calbiochem. Dowex 50W-
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XB was purchased from Bio-Rad Laboratories. Aquasol II scintillation 
cocktail was purchased from New England Nuclear. 
the Student's paired t-test and the statistical significance as dermed in 
the text. 
Preparation of Labeled Unhydroxylated Substrate 
Labeled unhydroxylated collagen substrate was prepared from 15-
day-old chick calvaria incubated in 7.0 rnl of Dulbecco's lysine-free 
minimal essential medium with 3.0 mCi ofL-[4,5-3H] lysine (1 mCi/rnl) 
or 9.6 ml of medium with 400 J.lCi of L-[3,4-3H] proline (1 mCi/ml) as 
previously described by Peterkofsky and Diblasio [lB]. This preparation 
was supplemented with 0.5 mM a,a' -dipyridyl, aerated with 90% air-
10% CO2 and incubated for 3 hr at 37°. The calvaria were separated 
from the medium, then rinsed with cold 0.11 M NaCI-0.05M Tris-HCI, 
pH 7.4, containing 1 mM L-Iysine or L-proline and homogenized in 24 
rnl of 0.5 N acetic acid in a Teflon-glass tissue homogenizer. The 
preparation was centrifuged at 20,000 g for 30 min and the clarified 
supernatant dialyzed against 0.4 M NaCI-0.1 M Tris-HCI, pH 7.6 for 4B 
hr before precipitating with 176 mg/ml of solid ammonium sulfate (30% 
saturated solution) . The precipitate was dissolved in 0.2 M NaCI-0.05M 
Tris-HCI, pH 7.6 and dialyzed against the same buffer. This dialyzed 
solution was warmed to 37° for 1.5 hr to allow fibril formation by 
unlabeled soluble collagen. Associated fibrils were pelleted by centrif-
ugation at 20,000 g for 10 min to enhance the specific activity of the 
final substrate preparation. Approximately 5 rnl of L-[4,5-3H] Iysine-
labeled (2.7 X 107 dpm/rnl) or L-[3,4-3H] proline-labeled (4.7 X 106 
dpm/ ml) unhydroxylated collagen substrate were obtained and stored 
in aliquots at -20°C. Each experiment with the mutant and control 
cell lines was performed with the same substrate preparations since 
others have found different substrate preparations had different specific 
activities [13,19]. 
Fibroblast Culture and Enzyme Preparation 
Skin biopsy material was obtained by punch biopsy and grown in 
monolayer cultures using Dulbecco and Vogt's modified Eagle's media 
supplemented with 15% fetal calf serum and glutamine by previously 
described methods [20]. Cells were seeded at 6.2-7.0 X 10' cells/ml (100 
ml medium) in 690 cm2 Belco roller bottles, grown to copfluence, 
harvested 2 days postconfluence with trypsin, and pelleted. The pellet 
was resuspended at a density of 2.5-3.0 X 10" cells/ml in 0.2 M NaCI-0.1 
M glycine-50 J.lM DTT-20 mM Tris-HCI buffer, pH 7.5, with rapid 
freezing and thawing 3 times before centrifuging at 15,000 g for 10 min 
at 4°C. Supernatant was either used immediately or dialyzed for 24 hr 
at 4°C against a 0.15 M NaCI-0.1 M glycine-50 J.lM DTT-20 mM Tris-
HCI buffer, pH 7.5, and frozen at -20°C for no more than one week. 
Dialysis of subcellular preparations from human fibroblast cultures 
had previously been used in this laboratory to clarify the relative 
requirements of aqueous soluble cofactors involved in complex enzyme 
reactions [21,22]' Activity of dialyzed enzyme was stable for 4 weeks at 
-20°C: Protein content was determined by a modified method of Lowry 
et al [23]. 
Enzyme A ssay 
Lysyl hydroxylase activity was determined by the tritium exchange 
method of Peterkofsky and Di Blasio with minor modification [lB]. 
Approximately 310,000 dpm of L-[ 4,5-"H] Iysyl collagen substrate were 
incubated with 80 J.!l of fibroblast lysate for 20 min at 30°C in a final 
volume of 0.5 ml. The reaction mixture contained 50 mM Tris-HCI 
adjusted to pH 7.5 at 30°C, 0.5 mM a-ketoglutarate, 0.0 to 1.0 mM L-
ascorbate, 0.1 mg catalase, 0.05 mM Fe(NH,hSO" 0.75 mg bovine serum 
albumin (BSA) and 0.1 roM DTT. The assay was stopped by the 
addition of 50 J.l1 of 50% trichloroacetic acid (TCA). Fifteen J.l1 of BSA 
(25 mg/ ml) were added to the assay tubes with mixing and kept on ice 
15 min. After centrifugation at 15,000 g for 5 min, the combined 
supernatants from the original centrifugation and one wash with 5% 
TCA were applied to 2.5 cm columns of AG Dowex 50W-XB. Eluant 
was collected in scintillation vials and mixed with 8 rnl of Aquasol II for 
counting in a Nuclear Chicago Mark I liquid scintillation counter with 
33% efficiency. Prolyl hydroxylase activity was measured by the same 
procedure except that the reaction mixture contained 47,000 dpm of L-
[3,4_3H] prolyl collagen substrate and 0.1 mM a-ketoglutarate. In both 
assays enzyme activity was defined as tritium released in the presence 
as compared to the absence of a-ketoglutarate unless otherwise stated. 
In experiments testing the effect of cupric ion on enzyme activity, 
albumin, catalase and dithiothreitol were omitted from the incubation 
mixture. Kinetic analysis was performed in a complete assay system 
lacking dithiothreitol. Lineweaver-Burke plots were generated by the 
method of least squares [24]. Statistical analysis was conducted with 
RESULTS 
Assay of Hydroxylase Activities from Cultured Fibroblasts 
Lysyl hydroxylase activity was evaluated in enriched cyto-
solic fractions of normal cultured human fibroblasts. In an 
initial assay containing 150 ,.,.g of cytosolic protein, enz~e­
dependent release of tritium was linear with respect to t~e 
over a 20 min period of incubation (Fig 1) . No increase m 
activity with increasing protein concentration was seen when 
a-ketoglutarate was omitted. Tritium release with 15 ,.,.1 ?f 
substrate plateaued at protein concentrations above 120 ,.,.g (FIg 
2). Addition of substrate, but not enzyme, during assay repro-
duced a linear relationship. All subsequent assays utilized 1.5 
,.,.1 of substrate preparation and approximately 60 ,.,.g of cytosohc 
protein in a 20 min incubation. Control enzyme activity· was 3 
to 4 times background. Background was defined as tritium 
released in the absence of the cosubstrate, a-ketoglutarate, 
unless otherwise stated (Fig 2) . 
The specificity and genetic control of lysyl hydroxylase im-
pairment were examined in cultured dermal fibroblasts from 
the proband, his parents and control cell lines. As seen in Table 
I, the mean lysyl hydroxylase activity in non dialyzed lysates of 
the patient's cells was 17% of the mean activity of age-matched 
controls. Activity was reduced at several different enzyme-pro-
tein concentrations (data not shown) . Mean activity in lysates 
from fibroblasts of the father and mother was 66% and 39%, 
respectively. The level of prolyl hydroxylase in these same 
lysates was within the range of activities expressed by control 
cells as was mitochondrial branched chain a-ketoacid dehydro-
genase. Fibroblasts obtained from normal individuals will ex-
press variable lysyl and prolyl hydroxylase activities when 
cultured under identical conditions as indicated by the standard 
deviations in Table I. Quantitation of variant lysyl hydroxylase 
activity by tritium-exchange assay is an arbitrary measurement, 
and caution should be exercised when utilizing percent of con-
trol activity as a determinant of enzyme deficiency. Quinn and 
Krane noted that the ratio of lysyl hydroxylase activity to 
prolyl hydroxylase activity best reflected the relative lysyl 
hydroxylase activity in a given cell lysate [13]. As shown in 
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FIG 1. Time-course of enzyme-dependent tritiated-water release 
from collagen ("H) Iysyl substrate. Incubation of dialyzed control cell 
cytosolic fraction containing 150 J.lg protein with 2.8 X 105 dpm (15 J.ll) 
and 4.7 X 10" dpm (25 ,.J) of substrate was carried out as described in 
the text. Data represent duplicate determinations with minus a-keto-
glutarate (KGA) blank values subtracted from each point. 
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FIG 2. Relationship between tritiated-water release and lysate pro-
tein content. Increasing amounts of control cell cytosolic fractions were 
assayed with 2.8 x 10" dpm (15,.d) and 4.7 x 10" dpm (25/-11) of substrate 
as outlined in the text. Mean tritium release in the presence and 
absence of a-ketoglutarate (KGA) is plotted for specified amounts of 
added protein. 
TABLE 1. Lysyl and prolyl hydroxylase activities in cultured skin. 
fibroblast lysates 
Enzyme Activities 
Cell line Lysyl Prolyl hydroxylase (LH) hydroxylase (PH) LH:PH (DPM "H release/mg (DPM "H release/mg 
protein/20 min) protein/ 20 min) 
Patient 3,505 ± 588 (8) 47,639 ± 8,881 (8) 0.074 
Mother 7,923 ± 495 (9) 24,572 ± 2,696 (6) 0.322 
Father 13,590 ± 1,569 (9) 56,680 ± 3,251 (6) 0.240 
Control-326 21,227 ± 1,360 (8) 45,289 ± 8,791 (8) 0.469 
Control-409 22,740 ± 1,277 (3) 40,976 ± 3,274 (3) 0.555 
Control-525 14,504 ± 665 (3) 18,455 ± 1,118 (3) 0.786 
Control-610 21,620 ± 1,455 (4) 29,213 ± 2,452 (4) 0.740 
Data are presented as the mean ± 1 standard deviation with the 
t otal number of enzyme assays in 2 sepaJ'ate experiments in parenthe-
ses. Control line 409 was assayed at 10 population doublings. The 
remaining cell lines were at 24-26 population doublings. 
Table I, this ratio best defmed the expressed genotype among 
the cell lines tested. 
Cofactor Requirements of Control and Mutant Enzyme 
Cofactor requirements for dialyzed lysyl hydroxylase were 
assessed. Subcellular enzyme preparations were exhaustively 
dialyzed to assure removal of aqueous-soluble cofactors before 
reconstitution and assay. As seen in Fig 3, when dithiothreitol 
alone was omitted from the reaction, 89% of activity remained, 
indicating that this reducing agent was not a principal reductant 
for the reaction. When catalase, bovine serum albumin, or Fe2+ 
were omitted separately, lysyl hydroxylase activity was 91%, 
73%, and 63% of maximum activity, respectively. When L-
ascorbate was omitted only 4% of complete activity remained. 
When a-ketoglutarate alone was omitted, essentially no activity 
above that of a minus enzyme blank was present. 
The reducing properties and steric requirements of L-ascor-
bate action on dialyzed enzyme were investigated with analogs 
of L-ascorbate and unconjugated pteridine (Table II). Control 
activity was measured in the complete assay system without 
dithiothreitol but containing either 1 mM or 10 mM L-ascorbate. 
Isoascorbate, the D-arabinose isomer of L-ascorbate which 
exhibits a similar standard redox potential [25], reconstituted 
103% and 94% of control activity observed with 1 roM and 10 
mM ascorbate, respectively. Lysyl hydroxylase activity was 
stimulated to a lesser degree by 2-amino-4-hydroxy-6, 7-di-
m ethyl-5,6,7,8-tetrahydropteridine, a naturally occurring reduc-
ing agent structurally dissimilar from ascor bate. Lysyl h ydrox-
ylation in the presence of 1 mM and 10 mM tetrahydropteridine 
was 82% and 91% of control, respectively. Addition of equal 
concentrations of ascorbate and tetrahydropteridine were not 
additive . Activity in assays containing less than saturating levels 
of L-ascorbate and either 0.02 mM or 0.1 mM tetrahydropteri-
dine was reduced when compared to assays with ascorbate but 
lacking tetrahydropteridine (data not shown). Incubation of 
substrate, cofactors without enzyme and 0.01-10 mM tetrahy-
dropteridine revealed no evidence of nonspecific tritium release 
by pteridine. In marked contrast dehydroascorbate, the oxida-
tion product of L-ascorbate, produced minimal activity at a 
concentration of either 1 mM or 10 mM. These data indicated 
that the reducing properties of ascorbate are required for hu-
man lysyl hydroxylase activity and that tetrahydropteridine 
but not dithiothreitol can partially substitute as a reducing 
agent. 
Ascorbate Interaction with Lysyl Hydroxylase 
Certain divalent cations interfere with lysyl and prolyl hy-
droxylase activities by competing with ferrous ion for binding 
at the active site [26,27]. This enzyme-ferrous ion locus could 
also serve as a site of ascorbate interaction with the active 
enzyme complex. Inhibition of human lysyl hydroxylase with 
Cu2+ defined Cu2+ as a site-specific probe and enabled further 
exploration of ascorbate interaction with the enzyme complex. 
Our kinetic analysis defined competitive inhibition of iron-stim-
ulated enzyme activity by cupric ion (Fig 4) . An increase in 
ferrous ion concentration increased lysyl hydroxylase activity 
in the presence of fixed inhibitor concentration. Double recip-
rocal plots converged at a common ordinate intercept, indicat-
ing an identical apparent maximal velocity. A replot of slopes 
of the reciprocal plots against inhibitor concentration was lin-
ear, indicating that copper inhibition was unique to iron-specific 
binding sites (data not shown). The apparent K; determined by 
extrapolation was 7 f.l.M. As indicated in Fig 4, 32 f.l.M Cu2+ 
inhibited enzyme activity with identical ordinate but different 
abscissal intercepts from 64 f.l.M Cu2+ 
To study the effects of ascorbate on copper inhibited lysyl 
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FIG 3. Cofactor requirements for tritiated-water release from ("H) 
Iysyl substrate by human lysyJ hydroxylase. Complete assay system 
contained: Dialyzed control cytosolic fraction (60 p.g protein) , substrate 
(2.8 X 10" dpm) , 0.1 mM dithiothreitol (DTT) , 1.5 mg/ rnl bovine serum 
albumin (BSA) , 0.2 -mg/ ml catalase, 0.05 mM ferrous ion (Fe2+), 0.5 
mM a-ketoglutarate (KGA) and 0.5 mM L-ascorbate. Isolated omissions 
aJ'e indicated. Data represent the mean of quadruplicate observations 
for each condition and are expressed as percent of maximum, the 
activity of the complete system. 
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TABLE II. Effect of L-ascorbate, ascorbate analogs and 
tetrahydropteridine on lysyl hydroxylase activity 
Activity Percent 
Reducing agent (DPM ' H release/mg Control 
protein/20 min) activity 
L-ascorbate 
1.0 mM 17,724 100 
10.0 mM 17,931 100 
Isoascorbate 
1.0 mM 18,226 103 
10.0 mM 16,912 94 
Tetrahydropteridine 
1.0 mM 14,469 82 
10.0 mM 16,249 91 
L-Ascorbate and 
terahydropteridine 
1.0 mM + 1.0 mM 18,708 106 
10.0 mM + 10.0 mM 15,995 89 
Dehydroascorbate 
1.0 mM 883 5 
10.0 mM 1,582 9 
Each reaction contained the complete assay system minus dithio-
threitol and the reducing agent specified in the left column. Activity 
was determined under standard conditions and represented the mean 
of quadruplicate observations for each reductant in 2 separate experi-
ments. 
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FIG 4. Double reciprocal plots of lysyl hydroxylase activity and Fe"+ 
in the presence of Cu2+. The concentrations of Cu2+ were: 64/LM (."), '32 
/LM (_), none (0 ). Data represent the mean of 4 determinations from 
2 separate experiments. A modified assay system lacking bovine serum 
albumin, catalase and dithiothreitol was incubated under standard 
conditions. 
hydroxylase, enzyme activity was quantitated over ascorbate 
ranges from 0.01 to 1.0 mM (Table III). At Fe2+ /Cu2+ ratios of 
1/32 and 5/ 32 similar augmentation by ascorbate was seen. The 
percent inhibition of optimum activity was constant at each 
concentration of ascorbate as was the ratio of activity between 
these 2 levels of inhibition by Cu2+ (A:B of Table III). These 
data confirm that Cu2+ inhibits Fe2+ binding or function at an 
active site on human lysyl hydroxylase, where iron is loosely 
bound to the enzyme complex. While subsaturable copper bind-
ing reduced enzyme activity, it did not prevent ascorbate inter-
action with remaining active enzyme. 
The effect of L-ascorbate on the thermostability of control 
and mutant enzyme was investigated with cell-free cytosolic 
fractions (Fig 5) . Aliquots of dialyzed enzyme were preincubated 
at 55° for varying periods of time in the presence or absence of 
1.0 mM L-ascorbate. After 10 min of preincubation the specifIc 
activities of both control and mutant enzyme were substantially 
reduced. Preincubation for longer periods produced thermal 
Vol. 72, No.5 
inactivation to baseline activity. Although preincubation of 
mutant enzyme in the presence of ascorbate resulted in app~­
ent greater activity than its absence, the increase in spec c 
activity was not statistically significant (p > 0.1). These da~ 
suggested that the mechanism of ascorbate action was no 
primarily to promote thermostability of the enzyme compl~x. 
L-ascorbate was not effective in increasing the relative actiVIty 
of mutant enzyme when exposed to elevated temperatures for 
increasing periods of time (data not shown). 
The effects of increasing L-ascorbate concentration on con-
trol and mutant lysyl hydroxylase are shown in Fig 6. Data 
represent the average of 3 separate experiments with the 2 cell 
lines. Control enzyme activity rose rapidly as ascorbate was 
increased from 0.01 mM to an optimum concentration of 0.5 
mM. Further increase to 1.0 mM did not further augment enzyme 
activity. Enzyme activity from the patient's cells also was 
maximum at 0.5 mM ascorbate, but plateaued at a level 17% of 
control. These data were analyzed by Lineweaver-Burke plO~ 
in Fig 7. Control enzyme had an apparent Vma• (4 X 104 dpm 
mg protein/20 min) approximately 4 times that observed for 
mutant enzyme (104 dpm/mg protein/20 min) . The app~ent 
Km of control and mutant enzyme for L-ascorbate deterrnmed 
from extrapolated abscissal intercepts was identical (100 p.M) . 
TABLE III. Effect of L-ascorbate concentration on copper-inhibited 
lysyl hydroxylase activity 
Ascorbate 
concentration (mM) 
0.01 
0.05 
0.1 
0.25 
0.5 
1.0 
Activity (DPM "H release/mg 
protein/20 min) 
A B 
l/LM Fe2+ 5/LM Fe2+ 
32/LM Cu2+ 32/LM Cu2+ 
1164 1667 
1541 2185 
1788 2334 
1836 2246 
1846 2246 
1868 2300 
A:B 
0.70 
0.71 
0.77 
0.82 
0.82 
0.81 
Each reaction contained a modified assay system with a-ketoglutar-
ate as well as ascorbate, ferrous ion, and cupric ion as indicated. 
Dithiothreitol, bovine serum albumin, and catalase were excluded. 
Activity was determined under standard conditions, and represented 
the mean of quadruplicate observations for each experimental point. 
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FIG 5. Lysyl hydroxylase activity after preincubation of control and 
mutant enzyme with L-ascorbate. Preincubation conditions are de-
scribed in text. Data represent duplicate determinations under standard 
assay conditions after the specified period of preincubation. 
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FIG 6. Relationship of ascorbate concentration to control and mu-
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ously described with varying L-ascorbate concentrations. Data repre-
sent the mean value of determinations from 3 separate experiments 
with each cell line. In anyone experiment duplicate determinations of 
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FIG 7. Double reciprocal plots of the velocity of lysyl hydroxylase 
activity versus ascorbate concentration. Replot of data depicted in Fig 
6 obtained over an ascorbate range from 0.01 mM to 1.0 mM. Each point 
represents the mean value of at least 3 determinations obtained in 3 
separate experiments with each cell line. 
Thus, although this mutant enzyme complex had a reduced 
capacity for ascorbate as compared to control, both the control 
and mutant enzymes had a normal affinity for L-ascorbate. 
This result was quite different from the only other previously 
investigated mutant enzyme which had a decreased apparent 
Kill for ascorbate (13]. 
DISCUSSION 
Our recent description of a patient with mild Ehlers-Danlos 
syndrome (type VI) whose clinical status improved following 
administration of pharmacologic amounts of vitamin C sug-
gested that further study of ascorbate-enzyme interaction in his 
and control cells might clarify both the basic mechanisms of 
ascorbate action on collagen lysyl hydroxylase and the patho-
logical mechanisms producing an altered phenotype [8]. Data 
from parental and the proband's cultured cells confIrmed for 
the first time that deficiency of lysyl hydroxylase activity con-
formed to an autosomal recessive mode of inheritance. SignifI-
cant diminution of enzyme activity was observed in cytosolic 
fractions from cultured fIbroblasts of the patient, while prepa-
rations from both parents displayed intermediate activity. This 
genetic aberration was specifIc, since prolyl hydroxylase activ-
ities from all 3 cell lines were within the range of controls. 
The correlation between phenotypic expression and enzyme 
activity in cultured fIbroblasts suggested that the biochemical 
mechanisms producing an observed clinical response to large 
amounts of ascorbate might also be studied in vitro. After 
exhaustive dialysis our cytosolic preparation of lysyl hydroxyl-
ase required the reducing properties of ascorbate for enzyme 
activity. Another naturally occurring reducing agent tetrahy-
dropteridine could partially reconstitute activity but dithiothre-
itol and dehydroascorbate could not. How then might ascorbate 
act? At least 5 possible interactions were considered. First, 
ascorbate might promote conversion of an inactive proenzyme 
form or association of inactive subunits producing an active 
enzyme complex. Second, this reductant might exert a protec-
tive effect on the enzyme complex to reduce its biological or 
physical rate of degradation. A third possible mechanism would 
directly involve its reducing properties in promoting the gen-
eration or maintenance of non-specifIc enzymic sulfhydryl 
groups. Fourthly, L-ascorbate might act indirectly to maintain 
free iron it its reduced state during regeneration of the hydrox-
ylating system independently of a more extensive oxidation-
reduction system [28]. Finally, L-ascorbate might donate elec-
trons directly to the enzyme, possibly causing an alteration in 
the conformation of the enzyme and subsequently augmenta-
tion of lysyl hydroxylation. 
With respect to the fIrst hypothesis, the evidence from others 
mitigates its probability. There is no present evidence for 
proenzyme conversion or subunit association requiring L-ascor-
bate for lysyl hydroxylase. Studies by Miller indicated that 
lysyl hydroxylase activity in L-929 fIbroblasts was not depen-
dent upon ascorbate activation of an inactive precursor form 
[29]. Investigation by Kuttan, Cardinale and Udenfriend of 
prolyl hydroxylase activation in vitro suggested that conversion 
of smaller, cross-reacting protein to a larger, active complex 
was unlikely, and that activation by ascorbate was a direct 
cofactor actipn, causing release of active enzyme bound to 
underhydroxylated collagen in an inactive complex [30). To test 
further this hypothesis, investigators will need a purifIed lysyl 
hydl'Oxylase and its monospecifIc antibody. 
Perhaps ascorbate prolonged the biological half life of the 
enzyme complex by protecting it against degradation? Reduced 
activity expressed in mutant celllysates might reflect enzyme 
present in subnormal amounts as a result of enhanced rates of 
degradation. The question was approached indirectly by mea-
suring the effects of large amounts of ascorbate on the ther-
mostability of this enzyme. Ascorbate did not change the ther-
mal inactivation curves for control or mutant lysyl hydroxylase. 
Evidently, these pharmacological amounts of ascorbate were 
not protecting enzyme against thermal degradation as described 
for thiamine pyrophosphate on branched chain a -ketoacid de-
hydrogenase or pyridoxal phosphate on cystathionine synthase 
[31-34]. 
Thus, 3 possibilities for ascorbate interaction remained: a 
direct effect by maintaining specifIc -SH groups of the apoen-
zyme, an indirect effect by maintaining free ferrous ion and the 
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direct electron donation to the enzyme complex. The sulfhydryl 
nature of lysyl and prolyl hydroxylase was evidenced by the 
inhibition of lysyl hydroxylase activity by p-chloromecuroben-
zoate (PCMB), a reagent exhibiting high affinity for sulfhydryl 
groups, and the reversal of this inhibition by dithiothreitol 
[35]. Our data clearly demonstrated that the requirement for 
ascorbate was not satisfied by substitution with dithiothreitol, 
indicating that ascorbate did not act simply to maintain active 
-SH groups and must therefore function in a capacity different 
than dithiothreitol. 
It was possible that ascorbate functioned primarily to main-
tain free iron in the active ferrous form. Partial but not total 
loss of activity upon removal of ferrous ion indicated that L-
ascorbate could act without added ferrous ion. However, di-
alyzed lysyl hydroxylase might retain sufficient iron to allow 
partial activity without addition of free ferrous ion. Mainte-
nance of free ferrous ion in its reduced form should be more 
effectively performed by a reducing agent such as dithiothreitol 
with a greater electron donation potential. Our data showed 
that this was clearly not the case, since dithiothreitol failed to 
substitute for L-ascorbate. The reaction was totally dependent 
upon added ascorbate, even in the presence of freshly made 
Fe2+ solution. 
Certain divalent metal ions which exhibit a high affinity for 
-SH groups reduced lysyl and prolyl hydroxylase activities by 
competing with Fe2+ for binding at the active site 
[26,27,36,37]. Our kinetic data indicated that cupric ion inhibi-
tion of human lysyl hydroxylase was competitive and was 
overcome by increasing ferrous ion concentration. The apparent 
Ki for copper ion was equal to the apparent Km of the enzyme 
for ferrous ion. The linear replot confirmed that copper 
uniquely competed for iron-specific binding sites. Although the 
exact nature of the ascorbate active site is unknown, direct 
electron donation through bound ferrous ion is one mechanistic 
possibility for ascorbate action that is consistent with this data. 
However, kinetic analysis of this complex multicomponent as-
sociation could not be further interpreted in the absence of a 
purified enzyme preparation. 
Direct electron donation by ascorbate to the enzymic complex 
at its ferrous ion binding site is supported by several observa-
tions from our studies. We found that activity reconstitution in 
dialyzed cell-free lysates achieved with L-ascorbate could be 
duplicated with D-isoascorbate, a stereoisomer with a similar 
electro~-donating potential [25]. Dehydroascorbate, the oxi-
dized form of ascorbate, could not satisfy the ascorbate require-
ment without added reductant. The failure of dehydroascorbate 
to stimulate enzyme activity indicated that ascorbate was not 
regenerated from dehydroascorbate and that the 2 compounds 
did not function in a coupled oxidation-reduction system as 
cyclic electron carriers. The failure of the oxidized but sterically 
similar cofactor to augment activity also suggested that ascor-
bate did not function as an inert ligand or an energy source 
conferring more effective conformational changes or stability to 
the holoenzyme complex. The nature of interaction of ascorbate 
with control and mutant lysyl hydroxylase from our patient 
was similar. Assay of mutant enzyme activity from cultured 
cells of our patient revealed a reduced capacity (smaller appar-
ent V max ) for lysyl hydroxylation when compared with control 
enzyme, but both systems displayed an equal affinity (identical 
apparent Km) for ascorbate. We conclude from the above find-
ings that the observed clinical responses to pharmacological 
amounts of ascorbate reflected this cofactor's action as electron 
donor at a ferrous ion-containing site of this enzyme complex. 
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Announcements 
The Ninth Ibero Latin-American Congress of Dermatology is going to be held in Medellin, Colombia 
from November 24 to 29, 1979. For information please write to Alonso Cortes, M.D .-Apartado aereo # 
054613 Medellin-Colombia South America. 
Thanking you in advance, Alonso Cortes, M.D., Apartado Aereo # 054613, Medellin-Colombia, South 
America. 
The VIIIth International Congress on Photobiology will be held on July 20 to 25,1980, at the University 
of Louis Pasteur in Strasbourg, France. The program will include invited speakers for Symposia and 
Lectures. Free communications may be presented at poster sessions and round table discussions. For 
further information contact M. Charlier, Secretary General, Centre de Biophysique Moleculaire, lA, 
Avenue de la Recherche Scientifique, 45045 Orleans Cedex, France. 
